CDKN2A and thyroid gland undifferentiated (anaplastic) carcinoma: Additionally, a transcriptome analysis revealed that CDKN2A deletions in ATC correlated with lower thyroid differentiation scores, suggesting that CDKN2A status may be a prognostic marker for advanced differentiated and anaplastic thyroid cancer [74].